BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2425182)

  • 1. Adenosine receptors in an enriched fraction of plasma membranes from canine ventricular myocardium.
    Lee JT; Newman WH; Webb JG
    J Cardiovasc Pharmacol; 1986; 8(3):621-8. PubMed ID: 2425182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.
    Hüttemann E; Ukena D; Lenschow V; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):226-33. PubMed ID: 6328333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine receptor-mediated inhibition of cardiac adenylyl cyclase activity may involve multiple receptor subtypes.
    Ma H; Yu HJ; Green RD
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):81-6. PubMed ID: 8139704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labelling of Ri adenosine receptors in rat fat cell membranes with (-)-[125iodo]N6-hydroxyphenylisopropyladenosine.
    Ukena D; Furler R; Lohse MJ; Engel G; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):233-40. PubMed ID: 6089004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 5'-N-ethylcarboxamido[3H]adenosine binding to pig aorta smooth muscle membranes.
    Diocee BK; Souness JE
    Biochem Pharmacol; 1987 Nov; 36(21):3621-7. PubMed ID: 2823828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium.
    Musser B; Morgan ME; Leid M; Murray TF; Linden J; Vestal RE
    Eur J Pharmacol; 1993 Jul; 246(2):105-11. PubMed ID: 8397091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of N-ethylmaleimide on adenosine receptors of rat fat cells and human platelets.
    Ukena D; Poeschla E; Hüttemann E; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):247-53. PubMed ID: 6092976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of adenylate cyclase coupled adenosine receptors in guinea pig ventricular membranes.
    Leung E; Johnston CI; Woodcock EA
    Biochem Biophys Res Commun; 1983 Jan; 110(1):208-15. PubMed ID: 6301440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
    Ramkumar V; Barrington WW; Jacobson KA; Stiles GL
    Mol Pharmacol; 1990 Feb; 37(2):149-56. PubMed ID: 2304450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory adenosine receptors in the heart: characterization by ligand binding studies and effects on beta-adrenergic receptor stimulated adenylate cyclase and membrane protein phosphorylation.
    Hosey MM; McMahon KK; Green RD
    J Mol Cell Cardiol; 1984 Oct; 16(10):931-42. PubMed ID: 6151002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential desensitization of A1 adenosine receptor-mediated inhibition of cardiac myocyte contractility and adenylate cyclase activity. Relation to the regulation of receptor affinity and density.
    Liang BT; Donovan LA
    Circ Res; 1990 Aug; 67(2):406-14. PubMed ID: 2376079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of adenosine A1-receptor binding sites in bovine retinal membranes.
    Woods CL; Blazynski C
    Exp Eye Res; 1991 Sep; 53(3):325-31. PubMed ID: 1936168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Murayama T; Itahashi Y; Nomura Y
    J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
    Gerwins P; Nordstedt C; Fredholm BB
    Mol Pharmacol; 1990 Nov; 38(5):660-6. PubMed ID: 2172773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between adenosine receptors and adenylate cyclase in the smooth muscle of guinea pig myometrium.
    Smith MA; Silverstein JL; Westfall DP; Buxton IL
    Cell Signal; 1989; 1(4):357-65. PubMed ID: 2642029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.
    Liang BT
    J Pharmacol Exp Ther; 1989 Jun; 249(3):775-84. PubMed ID: 2732946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding.
    Linden J
    Mol Pharmacol; 1984 Nov; 26(3):414-23. PubMed ID: 6092894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of Ri-type adenosine receptors in bovine myocardium by radioligand binding.
    Lohse MJ; Ukena D; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):310-6. PubMed ID: 2984586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of high affinity and low affinity adenosine binding sites in human cerebral cortex.
    John D; Fox IH
    Adv Exp Med Biol; 1986; 195 Pt B():57-69. PubMed ID: 2429512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.